| Recruiting | Surgical Procedure Efficiency Evaluation stuDy NCT07228091 | Alcon Research | — |
| Withdrawn | UNITY VCS Vitreoretinal Surgery NCT07054281 | Alcon Research | N/A |
| Not Yet Recruiting | Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy NCT06343961 | Jie Zhong | N/A |
| Unknown | Comparison of Restoration in Vitreous Hemorrhage Patients With DME After or Not Removing Inner Limiting Membra NCT05529589 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Completed | Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter NCT05710458 | The University of Hong Kong | N/A |
| Completed | Clareon Intraocular Lens Stability in Vitrectomy Patients: CLOVE Study NCT06383754 | The University of Hong Kong | N/A |
| Unknown | Pars Plana Vitrectomy With 25-gauge 20000 Cpm, Bevel-tip Cutter NCT04404296 | Peregrine Eye and Laser Institute | N/A |
| Completed | Refractive Changes Following Vitrectomy NCT04712786 | Bursa Retina Eye Hospital | — |
| Unknown | Oral Sedation in Vitreoretinal Surgery NCT04346095 | Rocky Vista University, LLC | Phase 4 |
| Completed | Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G NCT04859556 | The University of Hong Kong | N/A |
| Completed | IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes NCT06559488 | Universitas Padjadjaran | N/A |
| Unknown | Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy NCT05514925 | Khairallah Moncef | Phase 4 |
| Unknown | Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery NCT05588037 | Aier School of Ophthalmology, Central South University | N/A |
| Completed | Anti-VEGF vs. Prompt Vitrectomy for VH From PDR NCT02858076 | Jaeb Center for Health Research | Phase 2 / Phase 3 |
| Unknown | Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage NCT01824043 | Hospital Regional de São José - Dr. Homero de Miranda Gomes | Phase 4 |
| Completed | Aflibercept Injection for Proliferative Diabetic Retinopathy NCT01805297 | University of Oklahoma | Phase 2 |
| Completed | Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy NCT01724385 | Khon Kaen University | Phase 4 |
| Completed | Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Re NCT01854593 | Nihon University | Phase 4 |
| Completed | Different Hemostasis According to the Anesthetic Agents NCT02151305 | Seoul National University Bundang Hospital | N/A |
| Completed | Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) NCT00996437 | Jaeb Center for Health Research | Phase 2 / Phase 3 |
| Completed | Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy NCT00745498 | Seoul National University Bundang Hospital | N/A |
| Completed | Preoperative Bevacizumab for Vitreous Hemorrhage NCT00596297 | University of Sao Paulo | Phase 1 / Phase 2 |
| Completed | Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrecto NCT00155454 | National Taiwan University Hospital | N/A |
| Completed | 20- Versus 23- Gauge System for Pars Plana Vitrectomy NCT00411970 | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Phase 4 |
| Completed | Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage NCT00198497 | Bausch & Lomb Incorporated | Phase 3 |
| Completed | Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage NCT00198510 | Bausch & Lomb Incorporated | Phase 3 |
| Completed | Branch Vein Occlusion Study NCT00000162 | National Eye Institute (NEI) | Phase 3 |
| Completed | Diabetic Retinopathy Vitrectomy Study (DRVS) NCT00000154 | National Eye Institute (NEI) | Phase 3 |